Canadian Sec - Delayed Quote CAD

Predictmedix AI Inc. (PMED.CN)

0.0300

0.0000

(0.00%)

At close: April 28 at 11:28:24 AM EDT

Predictmedix AI Screening Technology Emerges as Strategic Asset Amid FDA’s Regulatory Shift Away from Animal Testing

TORONTO, April 11, 2025--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-driven health and safety solutions, welcomes the U.S. Food and Drug Administration’s (FDA) groundbreaking move to phase out mandatory animal testing in drug development. As the pharmaceutical and biotech industries pivot toward more ethical and technologically advanced methodologies, Predictmedix’s Smart Health AI Stations stand out as a scalable, non-inva

Business Wire 18 days ago

PMEDF
0.00%
Predictmedix AI Surpasses 500,000 Scans with Smart Health AI Stations

TORONTO, April 07, 2025--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-driven health and safety solutions, proudly announces a significant milestone: its Smart Health AI Stations have successfully completed over 500,000 individual scans. This achievement highlights the scalability, precision, and real-world impact of Predictmedix AI’s cutting-edge machine learning technology, transforming health and safety standards across he

Business Wire 22 days ago

PMEDF
0.00%
Predictmedix AI Announces Closing of $100,000 Third Tranche with Strong Insider Participation and Launch of Smart Health AI Stations

TORONTO, April 01, 2025--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-powered health screening solutions, is pleased to announce the successful closing of the third and the final tranche of its non-brokered private placement, raising total gross proceeds of $100,000 CAD. Notably, $90,000 of the tranche was subscribed by insiders, with Sheldon Kales and Dr. Rahul Kushwah each participating for $45,000, highlighting strong int

Business Wire 28 days ago

PMEDF
0.00%
Predictmedix AI Announces Closing of $405,500 Second Tranche with Strong Participation from German Family Offices

TORONTO, March 19, 2025--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-powered health screening solutions, is pleased to announce the successful closing of the second tranche of its non-brokered private placement, raising total gross proceeds of $405,500. Notably, this tranche saw strong participation from two prominent German family offices, underscoring growing international confidence in Predictmedix’s AI-driven innovation

Business Wire last month

PMEDF
0.00%
Predictmedix AI Launches Advanced AI Health Stations to Target the US Market

TORONTO, February 28, 2025--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), an innovative provider of AI-powered health screening solutions, is pleased to announce that it is launching its enhanced Smart Health AI Stations across the United States, positioning itself to capitalize on the rapidly expanding population health management market.

Business Wire last month

PMEDF
0.00%
Predictmedix AI Announces Closing of $320,000 First Tranche to Accelerate Commercialization

TORONTO, February 22, 2025--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider of AI-powered health screening solutions, is pleased to announce the successful closing of the first tranche of its non-brokered private placement. The Company issued 16,000,000 units ("Units") at an issue price of $0.02 per Unit, raising gross proceeds of $320,000.

Business Wire 2 months ago

PMEDF
0.00%
Predictmedix AI: Corporate Update & Strategic Focus on AI Health Management

TORONTO, February 12, 2025--Predictmedix AI (CSE: PMED | OTC: PMEDF | FRA: 3QP) (the "Company" or "Predictmedix") is repositioning itself as an emerging leader in AI-powered health management technologies, with a strategic shift toward solutions that go beyond traditional healthcare. The Company’s approach emphasizes workplace safety, workforce readiness, and public sector health screening—areas where AI-driven technologies can potentially offer scalable, impactful solutions without the regulato

Business Wire 2 months ago

PMEDF
0.00%
Predictmedix AI Announces Private Placement

TORONTO, February 11, 2025--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA:3QP) (the "Company" or "Predictmedix"), a leading provider of rapid health screening announces a proposed non brokered private placement. The Company intends to issue (the "Offering") of up to 50,000,000 units (each, a "Unit") at a price of C$0.02 per Unit, for aggregate gross proceeds to the Company of up to C$1,000,000. Each Unit will be comprised of one common share of the Company (each, a "Common Share") and one c

Business Wire 2 months ago

PMEDF
0.00%

Performance Overview

Return	PMED.CN	S&P/TSX Composite index (^GSPTSE)
YTD	+100.00%	+1.03%
1-Year	--	+13.01%
3-Year	-70.00%	+19.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Predictmedix AI Inc. (PMED.CN)

Predictmedix AI Screening Technology Emerges as Strategic Asset Amid FDA’s Regulatory Shift Away from Animal Testing

Predictmedix AI Surpasses 500,000 Scans with Smart Health AI Stations

Predictmedix AI Announces Closing of $100,000 Third Tranche with Strong Insider Participation and Launch of Smart Health AI Stations

Predictmedix AI Announces Closing of $405,500 Second Tranche with Strong Participation from German Family Offices

Predictmedix AI Launches Advanced AI Health Stations to Target the US Market

Predictmedix AI Announces Closing of $320,000 First Tranche to Accelerate Commercialization

Predictmedix AI: Corporate Update & Strategic Focus on AI Health Management

Predictmedix AI Announces Private Placement

Performance Overview